Condition
Hepatic Steatosis clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Hepatic Steatosis clinical trials that are recruiting, at sites in 5 countries (most in China (3), United States (2), United Kingdom (1)). By phase: Phase 2 (2), Phase 4 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 5Countries
Newest Hepatic Steatosis clinical trials
All recruiting trials (8)
-
Pre-hepatectomy rehabilitation with mazdutide for obese MASLD donors
This trial tests whether adding mazdutide to a structured lifestyle plan helps overweight MASLD donors lose liver fat faster to become eligible for donation.
-
Photon-counting CT and ultrasound for detecting liver fat and scarring
This will test whether a new photon-counting CT plus ultrasound can find liver fat and scarring in adults with fatty liver or liver fibrosis, using MRI as the reference.
-
Tesamorelin to reduce liver fat in adults with fatty liver disease
This trial tests whether a daily self‑injection of tesamorelin can lower liver fat over 52 weeks in adults with fatty liver disease.
-
Effects of exercise on liver glucose production in Type 2 diabetes and fatty liver
This study tests how exercise affects liver sugar production in people with Type 2 diabetes and fatty liver compared to healthy individuals.
-
New medication for treating liver diseases
This study is testing a new medication for people with liver diseases to see if it is safe and helps reduce liver fat and inflammation.
-
Investigating body fat distribution and its impact on metabolic diseases in Japanese adults
This study looks at how the way body fat is distributed affects the risk of metabolic and heart diseases in Japanese adults.
-
Investigating a new inflammatory marker's link to fatty liver disease and liver fibrosis
This study is trying to see if a new blood marker can help doctors diagnose fatty liver disease and liver scarring in people who have these conditions.
-
Effect of a fibre supplement on children with fatty liver disease
This study is testing whether a fiber supplement can help children aged 8-17 with fatty liver disease improve their liver health over six months.
Related topics
Quick answers
How many Hepatic Steatosis clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (3 trials), United States (2 trials), United Kingdom (1 trial), Canada (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.